Epidermal growth factor receptor and activated epidermal growth factor receptor expression in gastrointestinal carcinoids and pancreatic endocrine carcinomas.
about
Medical treatment for gastro-entero-pancreatic neuroendocrine tumoursFrom targets to treatments: a review of molecular targets in pancreatic neuroendocrine tumorsPI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasmsMicroRNA expression in ileal carcinoid tumors: downregulation of microRNA-133a with tumor progressionAn analysis of trends and growth factor receptor expression of GI carcinoid tumorsConcurrent inhibition of NF-kappaB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer.Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primariesGastrointestinal hormones stimulate growth of Foregut Neuroendocrine Tumors by transactivating the EGF receptor.Molecular markers for novel therapeutic strategies in pancreatic endocrine tumorsEndocrine tumours of the gastrointestinal tract-selected topics.Activated epidermal growth factor receptor in ovarian cancer.Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFREGF-receptor regulation of matrix metalloproteinases in epithelial ovarian carcinoma.Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology.Targeting the Mammalian Target of Rapamycin in Lung Cancer.Novel medical therapies of recurrent and metastatic gastroenteropancreatic neuroendocrine tumors.Translation of molecular pathways into clinical trials of neuroendocrine tumors.Research and innovation in the development of everolimus for oncology.Molecular pathogenesis of pancreatic neuroendocrine tumors.Molecular pathogenesis and targeted therapy of sporadic pancreatic neuroendocrine tumors.Potent antitumor activity of the novel HSP90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells.Genome-wide gene expression analysis of chemoresistant pulmonary carcinoid cells.Targeting mTOR pathway: A new concept in cancer therapy.EGFR-dependent pancreatic carcinoma cell metastasis through Rap1 activation.Treatment of gastrointestinal neuroendocrine tumors with inhibitors of growth factor receptors and their signaling pathways: recent advances and future perspectives.
P2860
Q26751659-51C0C1C5-1BE3-4726-B2B2-55A6A763DD72Q26822011-8C65873E-142D-4316-B6EB-89A8F24DA34AQ26862544-CC5BBB2D-9303-4376-8A67-D5D4F5D7CF70Q33520915-171AF5C3-5A7D-489B-8A00-D1D13A01D802Q33985773-1FB68442-E3CA-4119-9A8A-18387F38D477Q34979358-5D33A6FC-1700-4554-B85E-A5B44FC191F2Q35747269-4468B9FC-55F7-4A75-BD4E-3A9C11FF0DF7Q36565495-0DF2B9B8-F7E8-4F94-BD34-0A02327CCAB7Q36673960-BDCEA4E8-CEB0-4A52-BDCF-7C925D1FEE0EQ36699524-B6758BD4-A08B-4AE5-BE35-3D85946EB16DQ36981918-354F9E4F-DE0A-485E-BB65-51411B188F27Q37129376-C74AB65D-A0F3-4166-B34E-05CC41B39F08Q37260078-EF71B8E2-99FB-457B-824E-3D0B14505DA1Q37634917-3FF6A37F-D192-43F0-8F3F-7AFE5FACA7D0Q37741531-6BF656A4-A62B-4F09-88EA-40D70BD3D446Q37936908-B2FEEDC0-F412-4DDD-91E2-28EAF9ECB3F7Q38003074-8BAA3A65-90EC-44A4-BD2F-5F9256275F17Q38014589-DD017A4A-221D-43E1-89D9-D6BFE5D0EB48Q38166586-898822B0-014E-4E61-BDDC-D9A48A29B2A3Q38331666-1D966794-B11E-486F-9D80-5427E44736ABQ39084975-BF017261-21A1-438C-9130-06A0F752E4D5Q39660371-32FB99D9-E46B-4A21-9BD4-35D2CAD60CF0Q42728790-1F01D884-C66D-4F6D-B3C6-76332F9840F3Q43091585-45891A0B-D4F9-4039-8383-747FC6A1B3B4Q43097453-5C0B1179-E582-478B-9B4E-BB25F39BF1E8
P2860
Epidermal growth factor receptor and activated epidermal growth factor receptor expression in gastrointestinal carcinoids and pancreatic endocrine carcinomas.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Epidermal growth factor recept ...... ncreatic endocrine carcinomas.
@en
Epidermal growth factor recept ...... ncreatic endocrine carcinomas.
@nl
type
label
Epidermal growth factor recept ...... ncreatic endocrine carcinomas.
@en
Epidermal growth factor recept ...... ncreatic endocrine carcinomas.
@nl
prefLabel
Epidermal growth factor recept ...... ncreatic endocrine carcinomas.
@en
Epidermal growth factor recept ...... ncreatic endocrine carcinomas.
@nl
P2093
P2860
P1433
P1476
Epidermal growth factor recept ...... ncreatic endocrine carcinomas.
@en
P2093
Audrey L Rohlinger
Bettina Papouchado
Charles Erlichman
Lori A Erickson
Matthew M Ames
Ricardo V Lloyd
Timothy J Hobday
P2860
P2888
P304
P356
10.1038/MODPATHOL.3800427
P577
2005-10-01T00:00:00Z